7 min

JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab JAMA Neurology Author Interviews

    • Medicine

Interview with Eugene O. Major, PhD, author of JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab

  • American Medical Association, 2020

Interview with Eugene O. Major, PhD, author of JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab

7 min

  • American Medical Association, 2020

More by JAMA Network

JAMA Clinical Reviews
JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Medical News
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Pediatrics Editors' Summary
JAMA Pediatrics Editors' Summary
JAMA Network
JAMA Neurology Author Interviews
JAMA Neurology Author Interviews
JAMA Network
JAMA Internal Medicine Author Interviews
JAMA Internal Medicine Author Interviews
JAMA Network